A Study to Create and Maintain Plasma and Serum Bank for Patients with Thrombosis

Overview

About this study

The purpose of this study is to create and maintain a clinical database of patients with history of, or who are at high risk for thromboembolic diseases, along with a plasma/serum repository. We plan to evaluate novel biomarkers that might be associated with thromboembolic diseases and test whether these biomarkers will help predict the incident and recurrentrecurrences of thromboembolic episodes and other outcomes (e.g., mortality, post thrombotic syndrome).

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Individuals who have history of, or who are at high risk for either arterial or venous thromboembolism (e.g., DVT, pulmonary embolism, stroke, myocardial infarction, peripheral arterial ischemia)

Exclusion Criteria: 

  • Individuals who are not at a high risk for a history of arterial or venous thromboembolism.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Aneel Ashrani, M.D., M.S.

Closed for enrollment

Contact information:

No Contact

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20313598

Mayo Clinic Footer